Dianthus Therapeutics (DNTH) Operating Income Growth (1y) (2018 - 2025)
Dianthus Therapeutics (DNTH) Operating Income Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.37 Bn | 2.97 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -34.74% |
| Jun 30, 2025 | -57.30% |
| Mar 31, 2025 | -85.93% |
| Dec 31, 2024 | -146.34% |
| Sep 30, 2024 | -89.73% |
| Jun 30, 2024 | -88.55% |
| Mar 31, 2024 | -132.25% |
| Dec 31, 2023 | -21.16% |
| Sep 30, 2023 | -90.93% |
| Jun 30, 2023 | 34.88% |
| Mar 31, 2023 | 67.76% |
| Dec 31, 2022 | 46.91% |
| Sep 30, 2022 | 54.76% |
| Jun 30, 2022 | -2.69% |
| Mar 31, 2022 | -27.47% |
| Dec 31, 2021 | -5.64% |
| Sep 30, 2021 | 0.74% |
| Jun 30, 2021 | 12.00% |
| Mar 31, 2021 | 11.99% |
| Dec 31, 2020 | 22.62% |